Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Oncology

• Publication date

  2006-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2006.05.9584PMID 17135638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oestradiol potentiates the suppressive function of human CD4+ CD25+ regulatory T cells by promoting their proliferation

  2006cited by this paper
• Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

  2005cited by this paper
• Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single‐cell level

  2005cited by this paper
• Can Molecular Markers Predict When to Implement Treatment with Aromatase Inhibitors in Invasive Breast Cancer?

  2005cited by this paper
• Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

  2005cited by this paper
• Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells

  2005cited by this paper
• Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity.

  2005cited by this paper
• Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.

  2005cited by this paper
• Reporting recommendations for tumor marker prognostic studies.

  2005cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Cutting Edge: Estrogen Drives Expansion of the CD4+CD25+ Regulatory T Cell Compartment1

  2004cited by this paper
• A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

  2004cited by this paper
• Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast Carcinomas

  2004cited by this paper
• Regulatory T cells.

  2004cited by this paper
• Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

  2003cited by this paper
• Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1

  2002cited by this paper
• The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index

  1998cited by this paper
• CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production

  1998cited by this paper
• Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients.

  1993cited by this paper
• Factors predicting late mortality from breast cancer.

  1991cited by this paper
• Long-term survival of patients with breast cancer: a study of the curability of the disease.

  1979cited by this paper

• Prominent protumoral cellular compartments of the tumor microenvironment in triple-negative breast cancer

  2026cites this paper
• Expression of the immune checkpoint CD137/CD137L in oral squamous cell carcinoma (OSCC) and association with histopathological parameters.

  2026cites this paper
• ROSE12, a novel anti-CTLA-4 FcγRs binding-enhanced antibody activated by extracellular adenosine triphosphate, shows tumor-selective regulatory T-cell depletion and antitumor efficacy without systemic immune activation

  2026cites this paper
• Exploring the relationship between metabolism and immune microenvironment in breast cancer bone metastasis based on metabolic pathways

  2026cites this paper
• Prostaglandin E2-EP2/EP4 signaling induces the tumor-infiltrating Treg phenotype for tumor growth

  2025cites this paper
• Unraveling the microbiome's role in breast cancer progression and treatment response.

  2025cites this paper
• A FOXP3+ cell-rich microenvironment associates with better overall survival after CAR-T cell therapy in relapsed/refractory B-cell lymphoma.

  2025cites this paper
• Tumor-infiltrating lymphocytes in melanoma: diagnostic and prognostic implications from biopsy to circulation

  2025cites this paper
• Causal relationships between immune cell traits and HER2 subtypes in breast cancer: a Mendelian randomization study

  2025cites this paper
• Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer

  2025cites this paper
• Anti-HER2×CCR4 bispecific antibody enhances antitumor immunity in advanced HER2-positive tumors by chemotaxis blockade and depletion of tumor-associated Tregs, without inducing systemic toxicity

  2025cites this paper
• The role of interleukin-17 in inflammation-related cancers

  2025cites this paper
• Preliminary characterisation of the spatial immune and vascular environment in triple negative basal breast carcinomas using multiplex fluorescent immunohistochemistry

  2025cites this paper
• Regulatory T cells in the tumor microenvironment display a unique chromatin accessibility profile

  2025cites this paper
• Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells

  2025cites this paper
• Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancer

  2025cites this paper
• Tumor-infiltrating immune cells state-implications for various breast cancer subtypes

  2025cites this paper
• Morphofunctional changes in the immune system in colitis-associated colorectal cancer in tolerant and susceptible to hypoxia mice

  2025cites this paper
• Potential prognostic and immunologic significances of ADAM8 in clear cell renal cell carcinoma

  2025cites this paper
• Regulatory T cells in the tumour microenvironment

  2025cites this paper
• Interaction between the breast tumor microenvironment and gut microbiome

  2025cites this paper
• Association between FOXP3 Expression and Disease-Free Survival in Triple Negative Breast Cancer

  2025cites this paper
• The Trojan Horse Within: Mechanisms of Immune Evasion in Breast Cancer

  2025cites this paper
• Tumor cell dissemination is facilitated through regulatory T cell-driven extracellular matrix remodeling

  2025cites this paper
• Age-related aberrant alternative splicing as a prognostic tool in older breast cancer patients

  2025cites this paper
• Tumor-derived colorectal cancer organoids induce a unique Treg cell population by directing CD4+ T cell differentiation

  2025cites this paper
• A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer

  2025cites this paper
• Inside the Tumor: Decoding the Feline Mammary Tumor Microenvironment and Its Prognostic Value—A Review

  2025cites this paper
• The impact of immune cells on the risk of breast cancer: a Mendelian randomization study

  2025cites this paper
• Harnessing Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Opportunities and Barriers to Clinical Integration

  2025cites this paper
• Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1 study

  2025cites this paper
• Defining the Tumor-Bone axis: the role of extracellular vesicles in a crucial exchange route for breast cancer development and progression

  2025cites this paper
• The immunomodulatory role of tumor-initiating cells in digestive system tumors: from mechanisms to therapy

  2025cites this paper
• A novel Tc17 population recruited by tumor cells promotes tumor progression in gastric cancer

  2025cites this paper
• Impact of healthcare-associated infection on healthcare services and survival of patients with cancer: a propensity score-matched retrospective study

  2025cites this paper
• Interaction between redox regulation, immune activation, and response to treatment in HER2+ breast cancer

  2025cites this paper
• Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

  2025cites this paper
• Regulatory T Cells in Invasive Breast Cancer: Prognosis, Mechanisms and Therapy

  2025cites this paper
• Exploring predictive biomarkers of efficacy and survival with nivolumab treatment for unresectable/recurrent esophageal squamous cell carcinoma

  2025cites this paper
• Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers

  2025cites this paper
• A machine learning approach to risk-stratification of gastric cancer based on tumour-infiltrating immune cell profiles

  2025cites this paper
• Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer

  2025cites this paper
• Prognostic Significance of Regulatory CD25+ T Cells in Bladder Cancer: An Immunohistochemical Analysis

  2025cites this paper
• Immunometabolism of regulatory T cells in cancer

  2025cites this paper
• Decoding tumor-infiltrating lymphocytes heterogeneity in ductal carcinoma in situ: immune microenvironment dynamics and prognostic insights

  2025cites this paper
• Immune Biomarkers for Checkpoint Blockade in Solid Tumors: Transitioning from Tissue to Peripheral Blood Monitoring and Future Integrated Strategies

  2025cites this paper
• Mathematical models of intercellular signaling in breast cancer.

  2025cites this paper
• PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expression

  2024cites this paper
• The possible anti-tumor effects of regulatory T cells plasticity / IL-35 in the tumor microenvironment of the major three cancer types.

  2024cites this paper
• Tumor microenvironment and immunotherapy for triple-negative breast cancer

  2024cites this paper
• Clinical and prognostic effects of microvascular density and FOXP3 positive T cells in breast cancer

  2024cites this paper
• Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer

  2024cites this paper
• High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration

  2024cites this paper
• Thematic trends and knowledge-map of tumor-infiltrating lymphocytes in breast cancer: a scientometric analysis

  2024cites this paper
• Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium

  2024cites this paper
• IFI27 enhances bladder cancer immunotherapy response by modulating regulatory T cell enrichment

  2024cites this paper
• Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy

  2024cites this paper
• FoxP3+ Regulatory T-Cell Quantities in Nodal T-Follicular Helper Cell Lymphomas and Peripheral T-Cell Lymphomas Not Otherwise Specified and Their Impact on Overall Survival

  2024cites this paper
• FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor

  2024cites this paper
• Advances in predicting breast cancer driver mutations: Tools for precision oncology (Review)

  2024cites this paper
• Correlation of the abundance of MDSCs, Tregs, PD-1, and PD-L1 with the efficacy of chemotherapy and prognosis in gastric cancer.

  2024cites this paper
• The role of tumor microenvironment and self-organization in cancer progression: Key insights for therapeutic development

  2024cites this paper
• TRIP13: A promising cancer immunotherapy target

  2024cites this paper
• Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy

  2024cites this paper
• Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer

  2024cites this paper
• C6 and KLRG2 are pyroptosis subtype-related prognostic biomarkers and correlated with tumor-infiltrating lymphocytes in lung adenocarcinoma

  2024cites this paper
• Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects

  2024cites this paper
• Prognostic value of tumour-associated regulatory T-cells as a biomarker in non-small cell lung cancer: a systematic review and meta-analysis

  2024cites this paper
• Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrence

  2024influential citation
• DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants

  2024cites this paper
• Research Progress of Hypoxic Tumor Microenvironment in Tumorigenesis

  2024cites this paper
• Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development

  2024cites this paper
• Causal role of immune cells in thyroid cancer: a bidirectional Mendelian randomization study

  2024cites this paper
• Detailed Profiling of the Tumor Microenvironment in Ethnic Breast Cancer, Using Tissue Microarrays and Multiplex Immunofluorescence

  2024cites this paper
• Genetically evaluating the causal role of peripheral immune cells in colorectal cancer: a two-sample Mendelian randomization study

  2024cites this paper
• IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy

  2024cites this paper
• The effect of exercise and disease status on mobilization of anti-tumorigenic and pro-tumorigenic immune cells in women with breast cancer

  2024cites this paper
• Alteration of the immune microenvironment in the axillary metastatic lymph nodes of luminal A breast cancer patients

  2024cites this paper
• The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer

  2024cites this paper
• DNA Methylation-Derived Immune Cell Proportions and Cancer Risk, Including Lung Cancer, in Black Participants

  2024cites this paper
• Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice

  2024cites this paper
• Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis

  2024cites this paper
• YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53

  2024cites this paper
• Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs

  2024cites this paper
• Tumor-derived colorectal cancer organoids induce a unique Treg cell population through direct modulation of CD4+ T cell differentiation

  2024cites this paper
• Molecular changes in breast cancer induced by radiation therapy.

  2024cites this paper
• Inhaled anesthesia associated with reduced mortality in patients with stage III breast cancer: A population-based study

  2024cites this paper
• Convergence between helminths and breast cancer: intratumoral injection of the excretory/secretory antigens of the human parasite Toxocara canis (EST) increase lung macro and micro metastasis

  2024cites this paper
• Endothelial cells in tumor microenvironment: insights and perspectives

  2024cites this paper
• Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer

  2024cites this paper
• Biomarkers of minimal residual disease and treatment.

  2024cites this paper
• Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC)

  2024cites this paper
• The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy

  2024cites this paper
• Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.

  2024cites this paper
• The Dual Role of the NFATc2/galectin‐9 Axis in Modulating Tumor‐Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma

  2024cites this paper
• A new target of radiotherapy combined with immunotherapy: regulatory T cells

  2024cites this paper
• Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: Possible effects of in situ disorganized glucocorticoid production on tumor immunity.

  2024cites this paper
• Overexpression of NDRG1 leads to poor prognosis in hepatocellular carcinoma through mediating immune infiltration and EMT.

  2024cites this paper
• The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review

  2024cites this paper
• Implications of Senescent T Cells for Cancer Immunotherapy

  2023cites this paper